Market Tracker

04/17 6:05pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

6.98
Data as of Apr 17
 -0.02 / -0.29%
Today’s Change
5.83
Today|||52-Week Range
12.89
-5.55%
Year-to-Date

Today’s Trading

Previous close6.98
Today’s open6.93
Day’s range6.73 - 7.19
Volume82,346
Average volume (3 months)216,231
Market cap$337.1M
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)+76.89%
Earnings growth (this year)-18.37%
Earnings growth (next 5 years)--
Revenue growth (last year)+54.09%
P/E ratio0.2
Price/Sales14.53
Price/Book3.49

Competitors

 Today’s
change
Today’s
% change
DRTXDurata Therapeutics ...-0.11-0.86%
PPHMPeregrine Pharmaceut...+0.04+2.37%
ATNMActinium Pharmaceuti...+0.11+0.94%
DRNADicerna Pharmaceutic...+0.11+0.67%
Data as of 4:00pm ET, 04/17/2014

Financials

Next reporting dateMay 13, 2014
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$19.6M
Annual profit (last year)-$18.7M
Net profit margin-95.40%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, Director &
CAO
Kleanthis G. Xanthopoulos
Chief Scientific Officer
Neil W. Gibson
Corporate headquarters
San Diego, California

Forecasts